FI884471A7 - Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar - Google Patents

Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar

Info

Publication number: FI884471A7
Authority: FI; Finland
Prior art keywords: therapeutically active; dihydropyridine derivatives; preparing therapeutically; active dihydropyridine; preparing
Prior art date: 1987-09-30

Application number

FI884471A

Other languages

English (en)

Finnish (fi)

Other versions

FI884471A0 (sv

FI93444C (sv

FI93444B (sv

Inventor

Kelvin Cooper

Michael Jonathan Fray

Kenneth Richardson

John Steele

Original Assignee

Pfizer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-30

Filing date

1988-09-29

Publication date

1989-03-31

1987-09-30 Priority claimed from GB878722977A external-priority patent/GB8722977D0/en

1988-02-25 Priority claimed from GB888804441A external-priority patent/GB8804441D0/en

1988-09-29 Application filed by Pfizer Ltd filed Critical Pfizer Ltd

1988-09-29 Publication of FI884471A0 publication Critical patent/FI884471A0/sv

1989-03-31 Publication of FI884471A7 publication Critical patent/FI884471A7/sv

1994-12-30 Application granted granted Critical

1994-12-30 Publication of FI93444B publication Critical patent/FI93444B/sv

1995-04-10 Publication of FI93444C publication Critical patent/FI93444C/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyridine Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Thiazole And Isothizaole Compounds (AREA)

FI884471A 1987-09-30 1988-09-29 Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar FI93444C (sv)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB878722977A GB8722977D0 (en)	1987-09-30	1987-09-30	Therapeutic agents
GB8722977		1987-09-30
GB888804441A GB8804441D0 (en)	1988-02-25	1988-02-25	Therapeutic agents
GB8804441		1988-02-25

Publications (4)

Publication Number	Publication Date
FI884471A0 FI884471A0 (sv)	1988-09-29
FI884471A7 true FI884471A7 (sv)	1989-03-31
FI93444B FI93444B (sv)	1994-12-30
FI93444C FI93444C (sv)	1995-04-10

Family

ID=26292797

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI884471A FI93444C (sv)	1987-09-30	1988-09-29	Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar

Country Status (26)

Country	Link
US (3)	US4935430A (sv)
EP (1)	EP0310386B1 (sv)
JP (2)	JP2660016B2 (sv)
KR (1)	KR900008318B1 (sv)
CN (1)	CN1032648C (sv)
AU (2)	AU597190B2 (sv)
CA (1)	CA1340785C (sv)
CY (1)	CY1722A (sv)
DE (1)	DE3866077D1 (sv)
DK (1)	DK170376B1 (sv)
EG (1)	EG18563A (sv)
ES (1)	ES2038766T3 (sv)
FI (1)	FI93444C (sv)
GR (1)	GR3003468T3 (sv)
HK (1)	HK66093A (sv)
HU (1)	HU201061B (sv)
IE (1)	IE61045B1 (sv)
IL (1)	IL101332A0 (sv)
MY (1)	MY104933A (sv)
NO (1)	NO168107C (sv)
NZ (1)	NZ226397A (sv)
PH (1)	PH26046A (sv)
PL (1)	PL157186B1 (sv)
PT (1)	PT88614B (sv)
SG (1)	SG49393G (sv)
YU (1)	YU46698B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8906324D0 (en) *	1989-03-20	1989-05-04	Pfizer Ltd	1,4-dihydropyridines
US4990518A (en) *	1989-09-13	1991-02-05	G. D. Searle & Co.	Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines
GB9010404D0 (en) *	1990-05-09	1990-06-27	Pfizer Ltd	Therapeutic agents
GB9015524D0 (en) *	1990-07-13	1990-08-29	Pfizer Ltd	Therapeutic agents
GB9019409D0 (en) *	1990-09-05	1990-10-17	Pfizer Ltd	Therapeutic agents
DE69132006T2 (de) *	1990-11-30	2000-08-03	Otsuka Pharmaceutical Co., Ltd.	Thiazolederivate als inhibitoren von aktivem sauerstoff
US5288866A (en) *	1991-12-20	1994-02-22	American Cyanamid Company	5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids
DK40192D0 (da) *	1992-03-26	1992-03-26	Neurosearch As	Imidazolforbindelser, deres fremstilling og anvendelse
MY128323A (en)	1996-09-30	2007-01-31	Otsuka Pharma Co Ltd	Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
JP2002517396A (ja) *	1998-06-04	2002-06-18	アボット・ラボラトリーズ	細胞接着阻害抗炎症性化合物
WO2000075145A1 (en) *	1999-06-03	2000-12-14	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
AU2001279313B2 (en) *	2000-08-04	2007-03-01	Ampio Pharmaceuticals, Inc.	Method of using diketopiperazines and composition containing them
ES2572454T3 (es)	2003-05-15	2016-05-31	Ampio Pharmaceuticals Inc	Tratamiento de enfermedades mediadas por los linfocitos T
CN113999167B (zh) *	2021-10-18	2023-09-29	蚌埠中实化学技术有限公司	一种4-氯-2,6-二甲基-3-硝基吡啶的制备方法
CN117568743B (zh) *	2024-01-15	2024-03-19	江苏普坦科金属科技有限公司	一种铁基材料的表面耐腐蚀耐磨处理工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3971791A (en) *	1972-03-06	1976-07-27	Bayer Aktiengesellschaft	2-Amino-1,4-dihydropyridine derivatives
DE2738153A1 (de) *	1977-08-24	1979-03-08	Bayer Ag	2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2752820A1 (de) *	1977-11-26	1979-05-31	Bayer Ag	Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4285955A (en) *	1978-10-31	1981-08-25	Bayer Aktiengesellschaft	1,4-Dihydropyridinecarboxylic acids
US4317909A (en) *	1980-03-24	1982-03-02	Sterling Drug Inc.	Preparation of 1,3-dihydro-5-(pyridinyl)-2H-imidazo[4,5-b]pyridin-2-ones
US4353905A (en)	1981-09-17	1982-10-12	Warner-Lambert Company	Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US4414213A (en) *	1982-03-22	1983-11-08	Mead Johnson & Company	Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3363743D1 (en)	1982-07-22	1986-07-03	Pfizer Ltd	Dihydropyridine anti-ischaemic and antihypertensive agents
EP0125803A3 (en) *	1983-04-27	1987-01-21	FISONS plc	Pharmaceutically active dihydropyridines
JPS60120861A (ja) *	1983-12-02	1985-06-28	Otsuka Pharmaceut Co Ltd	ジヒドロピリジン誘導体
GB8620880D0 (en) *	1986-08-29	1986-10-08	Pfizer Ltd	Therapeutic agents
US4871745A (en) *	1986-09-22	1989-10-03	Ortho Pharmaceutical Corporation	2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
NO874194L (no)	1986-11-07	1988-05-09	Pfizer Ltd	Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
US4820842A (en) *	1986-11-19	1989-04-11	Warner-Lambert Company	2-substituted-1,4-dihydropyridines
GB8712747D0 (en) *	1987-05-30	1987-07-01	Pfizer Ltd	Therapeutic agents
GB8803963D0 (en) *	1988-02-19	1988-03-23	Pfizer Ltd	Therapeutic agents

1988
- 1988-09-26 MY MYPI88001070A patent/MY104933A/en unknown
- 1988-09-28 PT PT88614A patent/PT88614B/pt active IP Right Grant
- 1988-09-28 CA CA000578630A patent/CA1340785C/en not_active Expired - Fee Related
- 1988-09-29 YU YU182088A patent/YU46698B/sh unknown
- 1988-09-29 AU AU22973/88A patent/AU597190B2/en not_active Ceased
- 1988-09-29 FI FI884471A patent/FI93444C/sv not_active IP Right Cessation
- 1988-09-29 EP EP88309039A patent/EP0310386B1/en not_active Expired - Lifetime
- 1988-09-29 DK DK544588A patent/DK170376B1/da not_active IP Right Cessation
- 1988-09-29 IE IE294488A patent/IE61045B1/en not_active IP Right Cessation
- 1988-09-29 PL PL1988274977A patent/PL157186B1/pl unknown
- 1988-09-29 NO NO884333A patent/NO168107C/no unknown
- 1988-09-29 DE DE8888309039T patent/DE3866077D1/de not_active Expired - Lifetime
- 1988-09-29 ES ES198888309039T patent/ES2038766T3/es not_active Expired - Lifetime
- 1988-09-29 US US07/251,413 patent/US4935430A/en not_active Expired - Lifetime
- 1988-09-29 EG EG499/88A patent/EG18563A/xx active
- 1988-09-29 HU HU885063A patent/HU201061B/hu not_active IP Right Cessation
- 1988-09-29 NZ NZ226397A patent/NZ226397A/en unknown
- 1988-09-30 JP JP63247281A patent/JP2660016B2/ja not_active Expired - Fee Related
- 1988-09-30 PH PH37617A patent/PH26046A/en unknown
- 1988-09-30 KR KR1019880012718A patent/KR900008318B1/ko not_active Expired
- 1988-10-04 CN CN88109031A patent/CN1032648C/zh not_active Expired - Fee Related
1990
- 1990-05-01 US US07/517,116 patent/US5063237A/en not_active Expired - Lifetime
- 1990-05-01 US US07/517,115 patent/US5120747A/en not_active Expired - Lifetime
- 1990-08-23 AU AU61261/90A patent/AU617256B2/en not_active Ceased
1991
- 1991-12-30 GR GR91402199T patent/GR3003468T3/el unknown
1992
- 1992-03-22 IL IL101332A patent/IL101332A0/xx not_active IP Right Cessation
1993
- 1993-04-17 SG SG493/93A patent/SG49393G/en unknown
- 1993-07-08 HK HK660/93A patent/HK66093A/en not_active IP Right Cessation
1994
- 1994-05-06 CY CY172294A patent/CY1722A/xx unknown
1997
- 1997-01-31 JP JP9018645A patent/JP2898256B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1032439A (zh)	1989-04-19
PH26046A (en)	1992-01-29
US4935430A (en)	1990-06-19
YU182088A (en)	1990-06-30
EP0310386A3 (en)	1989-11-15
JPH01113367A (ja)	1989-05-02
IL101332A0 (en)	1992-11-15
IE882944L (en)	1989-03-30
JPH09315973A (ja)	1997-12-09
HU201061B (en)	1990-09-28
NO168107C (no)	1992-01-15
NO884333D0 (no)	1988-09-29
HK66093A (en)	1993-07-16
SG49393G (en)	1993-07-09
NZ226397A (en)	1990-11-27
PT88614A (pt)	1989-07-31
US5120747A (en)	1992-06-09
GR3003468T3 (en)	1993-02-17
US5063237A (en)	1991-11-05
JP2898256B2 (ja)	1999-05-31
EG18563A (en)	1993-08-30
AU617256B2 (en)	1991-11-21
NO884333L (no)	1989-03-31
FI884471A0 (sv)	1988-09-29
CA1340785C (en)	1999-10-12
EP0310386A2 (en)	1989-04-05
IE61045B1 (en)	1994-09-07
AU597190B2 (en)	1990-05-24
PL157186B1 (pl)	1992-05-29
DE3866077D1 (de)	1991-12-12
YU46698B (sh)	1994-04-05
JP2660016B2 (ja)	1997-10-08
EP0310386B1 (en)	1991-11-06
DK544588A (da)	1989-05-11
FI93444C (sv)	1995-04-10
DK544588D0 (da)	1988-09-29
NO168107B (no)	1991-10-07
PT88614B (pt)	1993-07-30
CN1032648C (zh)	1996-08-28
AU2297388A (en)	1989-04-06
AU6126190A (en)	1990-11-29
PL274977A1 (en)	1989-08-21
ES2038766T3 (es)	1993-08-01
DK170376B1 (da)	1995-08-14
CY1722A (en)	1994-05-06
KR890005054A (ko)	1989-05-11
FI93444B (sv)	1994-12-30
KR900008318B1 (ko)	1990-11-12
MY104933A (en)	1994-07-30
HUT48872A (en)	1989-07-28

Publication	Publication Date	Title
FI883050L (sv)	1988-12-25	Förfarande för framställning av terapeutiskt aktiva pyranoindolizinokinolinderivat
FI890652A7 (sv)	1989-08-11	Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
FI885409A7 (sv)	1989-05-24	Förfarande för framställning av nya terapeutiskt användbara pyridazinaminderivat
FI883249A7 (sv)	1989-01-11	Förfarande för framställning av terapeutiskt användbara 3-desmetylmevalonsyraderivat
FI870903L (sv)	1987-09-08	Förfarande för framställning av terapeutiskt aktiva med alfa-heterocykler substituerade tolunitriler
FI881180L (sv)	1988-09-14	Förfarande för framställning av terapeutiskt användbara tetrahydronaftalenderivat
FI882418A7 (sv)	1988-11-26	Förfarande för framställning av terapeutiskt aktiva cykliska aminderivat
FI883064A7 (sv)	1988-12-25	Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI892682L (sv)	1989-12-03	Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat
FI905941A7 (sv)	1991-06-07	Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI880757L (sv)	1988-08-21	Förfarande för framställning av terapeutiskt verkande omättade heterocykliska karboxamidderivat
FI893433A7 (sv)	1990-01-15	Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI890282L (sv)	1989-07-21	Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI883744L (sv)	1989-02-14	Förfarande för framställning av farmaceutiskt användbara indolderivat
FI892497L (sv)	1989-11-25	Förfarande för framställning av terapeutiskt aktiva bensamidderivat
FI880816A7 (sv)	1988-09-24	Förfarande för framställning av nya terapeutiskt användbara kinoxalinderivat
FI880869A7 (sv)	1988-08-26	Förfarande för framställning av terapeutiskt aktiva tetrazolderivat
FI883603A7 (sv)	1989-02-04	Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat
FI884471A7 (sv)	1989-03-31	Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI873350A7 (sv)	1988-02-05	Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat
FI884627A7 (sv)	1989-04-10	Förfarande för framställning av nya terapeutiskt användbara dideoxicytidinderivat
FI884553A7 (sv)	1989-04-06	Analogiförfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridinderivat
FI890283A7 (sv)	1989-07-21	Förfarande för framställning av terapeutiskt användbara 25-hydroxi-vitamin D-derivat
FI894803L (sv)	1990-04-12	Förfarande för framställning av terapeutiskt användbara kinolinonderivat
NO174959C (no)	1994-08-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater

Legal Events

Date	Code	Title	Description
1994-12-01	BB	Publication of examined application
2004-08-31	FG	Patent granted	Owner name: PFIZER LIMITED
2006-03-31	MA	Patent expired